Exchange: NASDAQ·Updated 04:35 PM EST
VRCA logo

VRCA Verrica Pharmaceuticals Inc

$2.79
$0.145
(5.03%)
Today
Closed $2.74
$0.05
(1.82%)
After Hours
Reported EarningsNov 12
Mkt Cap$49.56M
Vol127,031.00

About VRCA

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
39

Bearish Sentiment

How do you feel about VRCA?

Advertisement|Remove ads.